FDA approves Phase 1 trial for HIV gene therapy
The Pharma Data
AUGUST 24, 2020
The FDA has approved a request from American Gene Technologies to begin a clinical study into its HIV gene therapy. The treatment is being researched by scientists collaborating from American Gene Technologies, the Laboratory of Immunoregulation and the National Institute of Allergy and Infectious Diseases.
Let's personalize your content